The invention, its salt compound represented by Formula 1 below are new, a stereoisomer thereof, can be pharmaceutically acceptable or a precursor thereof {Kyozo} isomer {Isei} body, in vivo hydrolysable its mirror image provide. [Formula 1] In addition, it has excellent ability to differentiate osteoblasts, the compound of Formula 1, an innovative role osteoporosis, treatment of obesity and fatty liver in order to have a synthesis inhibitory activity of the fatty acids in the liver differentiation and ability to inhibit mast cell It is possible to accomplish.本発明は、新規な下記化学式1の化合物、その立体異性体、その鏡像{きょうぞう}異性{いせい}体、生体内で加水分解可能なその前駆体又は薬剤学的に許容できるその塩を提供する。【化1】また、前記化学式1の化合物は、造骨細胞の分化能に優れており、肥満細胞の分化抑制能及び肝臓における脂肪酸の合成抑制能を有するため骨粗鬆症、脂肪肝及び肥満治療に画期的な役割を果たすことができる。
